Anti-inflammatory properties of convolutamydine A and two structural analogues

Life Sciences

Volumn 116, Issue 1, 2014, Pages 16-24

  Fernandes, Patricia D ^a   Zardo, Renata S ^a   Figueiredo, Gabriella S M ^a   Silva, Bárbara V ^a   Pinto, Angelo C ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Anti inflammatory drugs; Convolutamydine A; Inflammation; Isatin

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; CONVOLUTAMYDINE A; CYCLOOXYGENASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; ISA 003; ISA 147; NITRATE; NITRIC OXIDE; NITRITE; OXINDOLE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CARRAGEENAN; CYTOKINE; FORMALDEHYDE; ISATIN; PTGS2 PROTEIN, HUMAN;

ACUTE TOXICITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CELL MIGRATION; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE COUNT; LEUKOCYTE MIGRATION; LICKING; MACROPHAGE; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTON NUCLEAR MAGNETIC RESONANCE; ANALOGS AND DERIVATIVES; ANIMAL; ANIMAL BEHAVIOR; BAGG ALBINO MOUSE; CELL LINE; CHEMISTRY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; INFLAMMATION; METABOLISM; PATHOLOGY; SYNTHESIS; TOXICITY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BEHAVIOR, ANIMAL; CARRAGEENAN; CELL LINE; CYCLOOXYGENASE 2; CYTOKINES; DINOPROSTONE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FORMALDEHYDE; INFLAMMATION; INTERLEUKIN-6; ISATIN; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84908271517     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2014.08.019     Document Type: Article

References (35)

1. Bartholomew B. A rapid method for the assay of nitrate in urine using the nitrate reductase enzyme of Escherichia coli. Food Chem Toxicol 1984;22:541-3.
2. Carter GT, Duong V, Ho S, Ngo KC, Greer CL, Weeks DL. Side effects of commonly prescribed analgesic medications. Phys Med Rehabil Clin N Am 2014;25:457-70.
3. Clancy R, Varenika B, Huang W, Ballou L, Attur M, Amin AR, et al. Nitric oxide synthase/COX cross-talk: nitric oxide activates COX-1 but inhibits COX-2-derived prostaglandin production. J Immunol 2000;165:1582-7.
4. Cravotto G, Giovenzana GB, Palmisano G, Penoni A, Pilati T, Sisti M, et al. Convolutamydine A: the first authenticated absolute configuration and enantioselective synthesis. Tetrahedron Asymmetry 2006;17:3070-4.
5. D'Acquisto F, Sautebin L, Iuvone T, Di Rosa M, Carnuccio R. Prostaglandins prevent inducible nitric oxide synthase protein expression by inhibiting nuclear factor-kappa B activation in J774 macrophages. FEBS Lett 1998;440:76-80.
6. da Silva JFM, Garden SJ, Pinto AC. The chemistry of isatins: a review from 1975 to 1999. J Braz Chem Soc 2001;12:273-324.
7. Di Rosa M. Biological properties of carrageenan. J Pharm Pharmacol 1972;24:89-102.
8. Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 1986;89:271-7.
9. Ershler WB, Keller ET. Age-associated increase interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med 2000;51:245-70.
10. Figueiredo GSM, Zardo RS, Silva BV, Violante FA, Pinto AC, Fernandes PD. Convolutamydine A and synthetic analogues have antinociceptive properties in mice. Pharmacol Biochem Behav 2013;103:431-9.
11. Garden SJ, Torres JC, Ferreira AA, Silva RB, Pinto AC.Amodified Sandmeyer methodology and the synthesis of (±)-convolutamydine A. Tetrahedron Lett 1997;38:1501-4.
12. Green LC, Wagner DA, Glogowski J, Skipper PL, Wisnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 1982;126:131-8.
13. Gurik TJ, Korbut R, Adamek-Gurik T. Nitric oxide and superoxide in inflammation and immune regulation. J Physiol Pharmacol 2003;54:469-87.
14. Harbrecht BG, Kim YM, Wirant EA, Simmons RL, Billiar TR. Timing of prostaglandin exposure is critical for the inhibition of LPS- or IFN-gamma-induced macrophage NO synthesis by PGE2. J Leukoc Biol 1997;61:712-20.
15. Hewawasam P, Erway M, Moon SL, Knipe J, Weiner H, Boissard CG, et al. Synthesis and structure- activity relationships of 3-aryloxindoles: a new class of calcium-dependent, large conductance potassium (Maxi-K) channel openers with neuroprotective properties. J Med Chem 2002;45:1487-99.
16. Hunskaar S, Hole K. The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain 1987;30:103-14.
17. Kamano Y, Zhang H-P, Ichihara Y, Kizu H, Komiyama K, Pettit GR. Convolutamydine A, a novel bioactive hydroxyl oxindole alkaloid from marine bryozoan Amathia convoluta. Tetrahedron Lett 1995;36:2783-4.
18. Lin WW, Chen BC, Hsu YW, Lee CM, Shyue SK. Modulation of inducible nitric oxide synthase induction by prostaglandinE2 in macrophages: distinct susceptibility inmurine J774 and RAW 264.7 macrophages. Prostaglandins Other Lipid Mediat 1999;58:87-101.
19. Lorke DA. New approach to practical acute toxicity testing. Arch Toxicol 1983;54:275-87.
20. Luppi G, Monari M, Corrêa RJ, Violante FA, Pinto AC, Kaptein B, et al. The first total synthesis of (R)-convolutamydine A. Tetrahedron 2006;62:12017-24.
21. Marnett LJ, Wright TL, Crews BC, Tannenbaum SR, Morrow JD. Regulation of prostaglandin biosynthesis by nitric oxide is revealed by targeted deletion of inducible nitric-oxide synthase. J Biol Chem 2000;275:13427-30.
22. Matheus ME, Violante FA, Garden SJ, Pinto AC, Fernandes PD. Isatins inhibit cyclooxygenase-2 and inducible nitric oxide synthase in a mouse macrophage cell line. Eur J Pharmacol 2007;556:200-6.
23. Oliveira SI, Fernandes PD, Mendes JGPA, Jancar S. Phagocytosis of apoptotic and necrotic thymocytes is inhibited by PAF-receptor antagonists and affects LPS-induced COX-2 expression in murine macrophages. Prostaglandins Lipid Mediat 2006;80:62-73.
24. Parada CA, Tambeli CH, Cunha FQ, Ferreira SH. The major role of peripheral release of histamine and 5-hydroxytryptamine in formalin-induced nociception. Neuroscience 2001;102:937-44.
25. Paya M, Pastor PG, Coloma J, Alcaraz MJ. Nitric oxide synthase and cyclo-oxygenase pathways in the inflammatory response induced by zymosan in the rat air pouch. Brit J Pharmacol 1997;120:1445-52.
26. Perkins DJ, Kniss DA. Blockade of nitric oxide formation down-regulatescyclooxygenase-2 and decreases PGE2biosynthesis in macrophages. J Leukoc Biol 1999;65:792-9.
27. Pinheiro MMG, Fernandes SB, Fingolo CE, Boylan F, Fernandes PD. Anti-inflammatory activity of ethanol extract and fractions from Couroupita guianensis Aublet leaves. J Ethnopharmacol 2013;146:324-30.
28. Popp FD, Parson R, Donigan BE. Synthesis of potential anticonvulsants, condensations of isatins with acetone and related ketones. J Pharmacol Sci 1980;69:1235-9.
29. Prestes-Carneiro LE, Shio MT, Fernandes PD, Jancar S. Cross-regulation of iNOS and COX-2 by its products inmurine macrophages under stress conditions. Cell Physiol Biochem 2007;20:283-92.
30. Raymundo LJRP, Guilhon CC, Alviano DS, Matheus ME, Antoniolli AR, Cavalcanti SCH, et al. Characterization of the anti-inflammatory and antinociceptive activities of the Hyptis pectinata (L.) Poit essential oil. J Ethnopharmacol 2011;134:725-32.
31. Silva BV. Isatin, a versatile molecule: studies in Brazil. J Braz Chem Soc 2013;24:707-20.
32. Silva BV, Torres JC, Garden SJ, Violante FA, Rezende MJC, et al. Quim Nova. 2008;31:924-9.
33. Swierkosz TA, Mitchell JA, Warner TD, Botting RM, Vane JR. Co-induction of nitric oxide synthase and cyclooxygenase: interactions between nitric oxide and prostanoids. Br J Pharmacol 1995;114:1335-42.
34. Tokunaga T, Hume WE, Umezome T, Okazaki K, Ueki Y, Kumagai K, et al. Oxindole derivatives as orally active potent growth hormone secretagogues. J Med Chem 2001;44:4641-9.
35. Vine KL, Matesic L, Locke JM, Ranson M, Skropeta D. Cytotoxic and anticancer activities of isatin and its derivatives: a comprehensive review from 2000-2008. Anti Cancer Agents Med 2009;9:397-414.